News from ajinomoto bio-pharma services A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages

Latest

05 May, 2020, 13:05 BST Ajinomoto Bio-Pharma Services Announces Manufacturing Partnership with CytoDyn for Drug Product Used in COVID-19 Clinical Trials

Ajinomoto Bio-Pharma Services ("Aji Bio-Pharma"), a leading provider of biopharmaceutical contract development and manufacturing services, is pleased ...


10 Mar, 2020, 10:00 GMT Ajinomoto Bio-Pharma Services Announces Formation of External Advisory Board

Ajinomoto Bio-Pharma Services ("Aji Bio-Pharma"), a leading provider of biopharmaceutical contract development and manufacturing services, announced...


29 Aug, 2019, 13:04 BST Ajinomoto Bio-Pharma Services Acquires Remaining Interest in Granules OmniChem Joint Venture in India

Ajinomoto Bio-Pharma Services ("Aji Bio-Pharma"), a leading provider of biopharmaceutical contract development and manufacturing services, announced...


08 Apr, 2019, 22:00 BST GeneDesign Joins Ajinomoto Bio-Pharma Services and Opens Oligonucleotide API Development Center

Ajinomoto Bio-Pharma Services ("Aji Bio-Pharma"), a leading provider of biopharmaceutical contract development and manufacturing services, is pleased ...


03 Apr, 2019, 11:00 BST Jean-Baptiste Agnus Joins Ajinomoto Bio-Pharma Services' Global Leadership Team as Vice President of Sales and Marketing

Ajinomoto Bio-Pharma Services ("Aji Bio-Pharma"), a leading global provider of bio-pharmaceutical contract development and manufacturing services, is ...


12 Mar, 2019, 11:00 GMT Ajinomoto Bio-Pharma Services Announces Capital Expansion to Fuel Growth

Ajinomoto Bio-Pharma Services ("Aji Bio-Pharma"), a leading global provider of bio-pharmaceutical contract development and manufacturing provided an...


18 Dec, 2018, 15:00 GMT Ajinomoto and XL-protein Forge Strategic Alliance to Develop PASylated Therapeutics Applying the Corynex® Platform

Ajinomoto Bio-Pharma Services, a fully owned subsidiary of Ajinomoto Co. Inc. (TSE: 2802), and XL-protein GmbH, a privately owned German...


28 Nov, 2018, 11:00 GMT Ajinomoto Bio-Pharma Services Introduces AJICAP Bioconjugation Technology for ADC Manufacturing

Ajinomoto Bio-Pharma Services ("Aji Bio-Pharma"), a leading provider of biopharmaceutical contract development and manufacturing services, presented...


02 Oct, 2018, 13:00 BST Ajinomoto Althea and OmniChem Combine to Form Ajinomoto Bio-Pharma Services, Reflecting a Collective Range of Services Offered to the Bio-Pharma Industry

Ajinomoto Althea and OmniChem, global leaders in large and small molecule contract manufacturing services, announced today that they are integrating...